Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma

Cesar A Virgen; Tuyet A Nguyen; Cosimo Di Raimondo; Arya Amini; Kim A Margolin; Vishwas Parekh; Farah R Abdulla; Badri Modi

doi:10.1016/j.jdcr.2020.01.008

Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma

JAAD Case Rep. 2020 Feb 19;6(3):195-197. doi: 10.1016/j.jdcr.2020.01.008. eCollection 2020 Mar.

Authors

Cesar A Virgen¹, Tuyet A Nguyen², Cosimo Di Raimondo^{3

4}, Arya Amini⁵, Kim A Margolin⁶, Vishwas Parekh⁷, Farah R Abdulla³, Badri Modi³

Affiliations

¹ Department of Dermatology, University of California-Irvine, Irvine, Los Angeles.
² Department of Dermatology, Kaiser Permanente-Los Angeles Medical Center, Duarte, California.
³ Division of Dermatology, City of Hope National Medical Center, Duarte, California.
⁴ Policlinico Tor Vergata, Rome, Italy.
⁵ Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.
⁶ Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, California.
⁷ Department of Pathology, City of Hope National Medical Center, Duarte, California.

No abstract available

Keywords: SCC, squamous cell carcinoma; bullous pemphigoid; cemiplimab; programmed cell death protein 1; programmed death ligand 1; rituximab; squamous cell carcinoma.

Publication types

Case Reports